AbCellera Biologics Investor Relations Material
Latest events
Q1 2025
AbCellera Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AbCellera Biologics Inc
Access all reports
AbCellera Biologics, Inc. operates as a biotechnology company. The Company offers antibody discovery platform that accelerates the design of therapeutic antibodies and helps researchers discover new treatments for people with cancer or Alzheimer's disease. The company's platform discovers and characterizes fully human antibodies from natural immune responses in order to provide insights into how best to stimulate the human immune system.
Key slides for AbCellera Biologics Inc
Q1 2025
AbCellera Biologics Inc
Q1 2025
AbCellera Biologics Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ABCL
Country
🇺🇸 United States